AKT1 and colorectal carcinoma: Zhang et al., demonstrated that the combination of cisplatin and metformin affected mitochondrial function in CRC cells by lowering mitochondrial membrane potential (MMP) and inducing reactive oxygen species (ROS) production, thereby promoting apoptosis through the PI3K/Akt pathway [47].